Fingerprint Dive into the research topics of 'Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer
Giulio Evangelisti, Fabio Barra, Melita Moioli, Paolo Sala, Sara Stigliani, Claudio Gustavino, Sergio Costantini, Simone Ferrero
Research output: Contribution to journal › Article › peer-review